Hong Cheng William, Amalou Hayet, Xu Sheng, Turkbey Baris, Yan Pingkun, Kruecker Jochen, Pinto Peter A, Choyke Peter L, Wood Bradford J
Center for Interventional Oncology, Clinical Center, National Cancer Institute, National Institutes of Health, 10 Center Drive MSC 1182, Bethesda, MD 20892.
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive MSC 1182, Bethesda, MD 20892.
J Vasc Interv Radiol. 2014 May;25(5):675-84. doi: 10.1016/j.jvir.2013.12.568. Epub 2014 Feb 26.
Prostate biopsies are usually performed by urologists in the office setting using transrectal ultrasound (US) guidance. The current standard of care involves obtaining 10-14 cores from different anatomic sections. Biopsies are usually not directed into a specific lesion because most prostate cancers are not visible on transrectal US. Color Doppler, US contrast agents, elastography, magnetic resonance (MR) imaging, and MR imaging/US fusion are proposed as imaging methods to guide prostate biopsies. Prostate MR imaging and fusion biopsy create opportunities for diagnostic and interventional radiologists to play an increasingly important role in the screening, evaluation, diagnosis, targeted biopsy, surveillance, and focal therapy of patients with prostate cancer.
前列腺活检通常由泌尿科医生在门诊环境中使用经直肠超声(US)引导进行。当前的护理标准包括从不同解剖部位获取10 - 14条组织芯。活检通常不针对特定病变,因为大多数前列腺癌在经直肠超声下不可见。彩色多普勒、超声造影剂、弹性成像、磁共振(MR)成像以及MR成像/超声融合被提议作为引导前列腺活检的成像方法。前列腺MR成像和融合活检为诊断和介入放射科医生在前列腺癌患者的筛查、评估、诊断、靶向活检、监测和局部治疗中发挥越来越重要的作用创造了机会。